Andreas Weber, Group CEO, EvidentIQ, discusses hybrid vs. fully decentralized trials, the use of real-world evidence (RWE) in clinical trials, and how an end-to-end eClinical solution can help meet increasing customer demand across clinical operations and clinical data management, plus much more!

To find out more about Impetus: https://www.meetwithimpetus.com

Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/

Impetus Digital Website: https://www.impetusdigital.com/

Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/

Impetus Digital Twitter: https://twitter.com/impetus_digital

Impetus YouTube: https://www.youtube.com/ImpetusDigital

Andreas Weber: https://www.linkedin.com/in/andreas-weber-916aa140/

EvidentIQ: https://www.evidentiq.com/